4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cardiff Oncology, Inc. (CRDF) operates in the Biotechnology industry and is headquartered in San Diego, United States with about 30 employees. Its market capitalization is roughly $61 million. In the fiscal year ended 2025-12-31, CRDF reported $1M in revenue and ($46M) in net income.
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer.
Interactive charts & full statements → Open the CRDF valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $0M | $0M | — |
| Operating Income (EBIT) | ($49M) | ($49M) | ($45M) | ($40M) | — |
| Net Income | ($46M) | ($45M) | ($41M) | ($39M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($13M) | ($8M) | ($12M) | ($15M) | ($14M) | — |
| Net Income | ($12M) | ($7M) | ($11M) | ($14M) | ($13M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $62M | $97M | $82M | $116M | — |
| Total Liabilities | $16M | $14M | $12M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRDF viewer.
About TickerBase · Data methodology & sources